Top Markets
Coin of the day
Actavia Life Sciences, Inc. Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc.

RASP
Rank in Stocks #39683
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing... Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Share Price
$0.0005
Last synced: 2026-08-12
Market Cap
$385.91K
Change (1 day)
0.00%
Change (1 year)
-87.50%
Country
US
Trade Actavia Life Sciences, Inc. (RASP)

Category

Operating Margin for Actavia Life Sciences, Inc. (RASP)
Operating Margin as of 2026 TTM: 0.00%
According to Actavia Life Sciences, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Actavia Life Sciences, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.